Basar Bilgicer

发表

Dependence of avidity on linker length for a bivalent ligand-bivalent receptor model system.

G. Whitesides, R. Perez-Castillejos, M. Butte, 2012, Journal of the American Chemical Society.

Neutralizing positive charges at the surface of a protein lowers its rate of amide hydrogen exchange without altering its structure or increasing its thermostability.

Bryan F. Shaw, G. Whitesides, S. Gygi, 2010, Journal of the American Chemical Society.

A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes.

Jonathan D. Ashley, T. Kiziltepe, J. F. Stefanick, 2013, ACS nano.

Design of a heterotetravalent synthetic allergen that reflects epitope heterogeneity and IgE antibody variability to study mast cell degranulation.

T. Kiziltepe, B. Bilgicer, Michael W Handlogten, 2013, The Biochemical journal.

Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy.

T. Kiziltepe, L. Littlepage, B. Bilgicer, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Functionalized liposome purification via Liposome Extruder Purification (LEP).

Jonathan D. Ashley, J. F. Stefanick, J. Ashley, 2013, The Analyst.

Enhanced cellular uptake of peptide-targeted nanoparticles through increased peptide hydrophilicity and optimized ethylene glycol peptide-linker length.

Jonathan D. Ashley, B. Bilgicer, Jared F. Stefanick, 2013, ACS nano.

Ligand-targeted liposome design: challenges and fundamental considerations.

Jonathan D. Ashley, T. Kiziltepe, G. Noble, 2014, Trends in biotechnology.

What potential do heterobivalent inhibitors have for the treatment of severe allergic reactions?

M. Kaplan, B. Bilgicer, Michael W Handlogten, 2014, Immunotherapy.

Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo.

X. Jing, T. Kiziltepe, Haihua Xiao, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo.

Xiabin Jing, Haihua Xiao, X. Jing, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Antibody purification via affinity membrane chromatography method utilizing nucleotide binding site targeting with a small molecule.

T. Kiziltepe, B. Bilgicer, N. Mustafaoglu, 2016, The Analyst.

Selective photocrosslinking of functional ligands to antibodies via the conserved nucleotide binding site.

Bryan F. Shaw, T. Kiziltepe, D. Moustakas, 2013, Biomaterials.

Conjugation of a reactive thiol at the nucleotide binding site for site-specific antibody functionalization.

B. Bilgicer, N. Mustafaoglu, N. Alves, 2014, Bioconjugate chemistry.

A coiled coil with a fluorous core.

B. Bilgicer, B Bilgiçer, A Fichera, 2001, Journal of the American Chemical Society.

Lysine acetylation can generate highly charged enzymes with increased resistance toward irreversible inactivation

George M Whitesides, Bryan F. Shaw, John M Neveu, 2008, Protein science : a publication of the Protein Society.

Site-specific conjugation of an antibody on a gold nanoparticle surface for one-step diagnosis of prostate specific antigen with dynamic light scattering.

T. Kiziltepe, B. Bilgicer, N. Mustafaoglu, 2017, Nanoscale.

Site‐specific fab fragment biotinylation at the conserved nucleotide binding site for enhanced ebola detection

B. Bilgicer, N. Mustafaoglu, N. Alves, 2015, Biotechnology and bioengineering.

Oriented Immobilization of Fab Fragments by Site-Specific Biotinylation at the Conserved Nucleotide Binding Site for Enhanced Antigen Detection.

B. Bilgicer, N. Mustafaoglu, N. Alves, 2015, Langmuir : the ACS journal of surfaces and colloids.

Identification of a moderate affinity CD22 binding peptide and in vitro optimization of peptide-targeted nanoparticles for selective uptake by CD22+ B-cell malignancies.

T. Kiziltepe, B. Bilgicer, Baksun Kim, 2020, Nanoscale.

In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma

T. Kiziltepe, L. Littlepage, B. Bilgicer, 2020, Journal of Hematology & Oncology.

Optimizing design parameters of a peptide targeted liposomal nanoparticle in an in vivo multiple myeloma disease model after initial evaluation in vitro.

Jonathan D. Ashley, T. Kiziltepe, B. Bilgicer, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Dual-receptor targeted strategy in nanoparticle design achieves tumor cell selectivity through cooperativity.

T. Kiziltepe, B. Bilgicer, David T. Omstead, 2019, Nanoscale.

Dual Carfilzomib and Doxorubicin–Loaded Liposomal Nanoparticles for Synergistic Efficacy in Multiple Myeloma

Jonathan D. Ashley, M. Suckow, T. Kiziltepe, 2016, Molecular Cancer Therapeutics.

Liposomal carfilzomib nanoparticles effectively target multiple myeloma cells and demonstrate enhanced efficacy in vivo.

Jonathan D. Ashley, M. Suckow, T. Hideshima, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Liposomal bortezomib nanoparticles via boronic ester prodrug formulation for improved therapeutic efficacy in vivo.

Jonathan D. Ashley, M. Suckow, T. Kiziltepe, 2014, Journal of medicinal chemistry.

Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9

J. Renauld, R. Flavell, M. Kaplan, 2022, Nature Communications.

Abnormal SDS‐PAGE migration of cytosolic proteins can identify domains and mechanisms that control surfactant binding

Bryan F. Shaw, Jonathan D. Ashley, Alejandro J. Ramirez, 2012, Protein science : a publication of the Protein Society.

Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo

Jonathan D. Ashley, M. Suckow, T. Kiziltepe, 2012, Blood Cancer Journal.